Part III.I Antileishmanial Chemotherapy Reviewed

Nitroimidazooxazoles# Part xxiv, Search for Antileishmanial Agents: 2,3-Dihydro-6-nitroimidazo[2,1-b]oxazoles as Potential Antileishmanial Agents

A number of mono and bicyclic nitroimidazoles were screened for in vitro antileishmanial activity. Among these, compounds belonging to the class of nitroimidazo[2,1-b]oxazoles showed moderate to good activity. This class of compounds had been reported previously to have pronounced antitubercular activity, particularly CGI17341 (5a). In the present study (5a) and (5d) and (7) were found to be mo...

Swarm Robotics Reviewed Swarm Robotics Reviewed

Jan Carlo Barca and Y. Ahmet Sekercioglu Robotica / Volume 31 / Issue 03 / May 2013, pp 345 ­ 359 DOI: 10.1017/S026357471200032X, Published online: 03 July 2012 Link to this article: http://journals.cambridge.org/abstract_S026357471200032X How to cite this article: Jan Carlo Barca and Y. Ahmet Sekercioglu (2013). Swarm robotics reviewed. Robotica, 31, pp 345­359 doi:10.1017/ S026357471200032X R...

I Iiii a Reconceptualization of Anxiety

Chemotherapy-induced peripheral neuropathy. Part II. Prevention

The incidence of chemotherapy-induced peripheral neuropathy (CIPN) in the population of cancer patients is estimated at 3-7% in cytostatic monotherapy and as high as 38% in the case of polytherapy. While testing drugs that may reduce the damage to the peripheral nervous system, particular attention should be paid to their protective action against the severe and painful complication in the pati...

Chemotherapy-induced polyneuropathy. Part I. Pathophysiology

Chemotherapy-induced peripheral neuropathy (CIPN) is a toxic neuropathy, a syndrome consisting of highly distressing symptoms of various degrees of severity. It includes numbness of distal extremities, long-term touch, heat, and cold dysaesthesia and, in more severe cases, motor impairment affecting daily functioning. Each form of the syndrome may be accompanied by symptoms of neuropathic sting...